Literature DB >> 660755

Renal cell carcinoma: natural history and results of treatment.

N P Patel, R W Lavengood.   

Abstract

We reviewed 166 cases of renal cell carcinoma. The presenting symptoms varied from vague backache to hypovolemic shock. The most common symptoms were pain, hematuria, a palpable mass and hypertension. Most cases involved were clear cell carcinoma (83 per cent) and survival was no better than in cases of granular cell carcinoma. The tumors metastasized to almost every organ of the body. Bilateral simultaneous primary renal cell carcinoma is described in 1 patient, who has survived for more than 5 years. The over-all 5-year survival rates of simple and radical nephrectomy were 32 and 66.6 per cent, respectively. Radiation therapy does not improve survival irrespective of stage. The 5-year survival rate with renal vein involvement was 32 per cent. Nephrectomy in patients with distant metastasis did not alter survival. Among the patients with metastasis 74 per cent were dead before 1 year and 96 per cent before 3 years.

Entities:  

Mesh:

Year:  1978        PMID: 660755     DOI: 10.1016/s0022-5347(17)57611-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  22 in total

Review 1.  Should there be a size limit for elective nephron-sparing surgery?

Authors:  Kent G Krejci; Bradley C Leibovich
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 3.092

2.  Incidence and prognostic significance of second primary cancers in renal cell carcinoma.

Authors:  Subhankar Chakraborty; Stefano R Tarantolo; Surinder K Batra; Ralph J Hauke
Journal:  Am J Clin Oncol       Date:  2013-04       Impact factor: 2.339

3.  Prognostic factors and the role of nephrectomy in metastatic renal cell carcinoma.

Authors:  M C Uygur; A Usubütün; H Ozen; A Ayhan; S Kendi
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

Review 4.  Interferon-alpha in malignant and viral diseases. A review.

Authors:  R T Dorr
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

5.  Significance of angiogenesis and microvascular invasion in renal cell carcinoma.

Authors:  Yoram Dekel; Rumelia Koren; Valentina Kugel; Pinhas M Livne; Rivka Gal
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

Review 6.  Oncological and renal medical importance of kidney-sparing surgery.

Authors:  Paul Russo
Journal:  Nat Rev Urol       Date:  2013-03-05       Impact factor: 14.432

7.  Biochemotherapy of advanced metastatic renal-cell carcinoma: results of the combination of interleukin-2, alpha-interferon, 5-fluorouracil, vinblastine, and 13-cis-retinoic acid.

Authors:  J Atzpodien; H Kirchner; S Duensing; E Lopez Hänninen; A Franzke; J Buer; M Probst; P Anton; H Poliwoda
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 8.  Evolving immunotherapeutic strategies in bladder and renal cancer.

Authors:  T R L Griffiths; J K Mellon
Journal:  Postgrad Med J       Date:  2004-06       Impact factor: 2.401

Review 9.  Solitary brain metastasis 13 years after removal of renal adenocarcinoma.

Authors:  M Ammirati; M Samii; G Skaf; A Sephernia
Journal:  J Neurooncol       Date:  1993-01       Impact factor: 4.130

10.  Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review.

Authors:  P C Kierney; J A van Heerden; J W Segura; A L Weaver
Journal:  Ann Surg Oncol       Date:  1994-07       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.